Status:
COMPLETED
E-Mental Health Adolescent Depression Program (LEAP)
Lead Sponsor:
Patricia Steele
Collaborating Sponsors:
Alberta Centre for Child, Family & Community Research
Alberta Health Services, Calgary
Conditions:
Depression
Eligibility:
All Genders
13-24 years
Phase:
NA
Brief Summary
The purpose of this project is to explore the potential value and practicality of an innovative depression intervention for young people. More specifically, the objectives of this project are: 1. to ...
Detailed Description
Depression in adolescents and young adults is a prevalent illness in Canada and presents a high burden for those affected and their families. In Canada, depressive disorders are on the rise and their ...
Eligibility Criteria
Inclusion
- 13-24 years of age
- meet DSM-IV-TR criteria for major depressive disorder (mild-moderate severity) based on the Children's Depression Rating Scale-Revised or the Hamilton Depression Rating Scale
- ability to comply with study intervention, provision of informed assent and/or parental consent
Exclusion
- In order to avoid confounding through a change in the use of mood altering substances or therapies and through underlying medical conditions, patients will be excluded for any of the following reasons:
- change in use of pharma-therapeutic or herbal treatment for depression in the last three month OR during the first 2 months of trial participation (mild to moderately depressed patients who have not had a change in their treatment in the last three months will be eligible to participate if it is foreseeable that their current treatment will continue unchanged for the first 2 months of trial participation)
- patients currently undergoing a specific psycho-therapeutic treatment that has been shown to be effective for depression (such as Cognitive Behavioral Therapy (CBT) or Interpersonal Therapy (IPT)) or planning to start such therapy in the next two months
- change in the use of medications that have mood altering effects in the last 3 months OR during the first 2 months of trial participation
- history of bipolar disorder, psychotic disorder or psychotic episodes, personality disorder, multiple suicide attempts; history of ADD/ADHD permitted if stabilized (no longer meets DSM-IV-TR criteria for active ADD/ADHD) for at least 2 months; stabilized treated ADD/ADHD permitted if on regular long acting medication and agree to continue
- uncontrolled medical conditions in the last 3 months (assessed by qualified physician)
- high suicide risk
- DSM-IV-TR diagnosis of substance dependence (except nicotine, caffeine) within past 12-months
- history of tx resistance to ≥ 2 antidepressant medications when treated for an adequate period with a therapeutic dose
- recent deaths in the family
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00985686
Start Date
January 1 2010
End Date
September 1 2012
Last Update
July 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Canadian Institute of Natural and Integrative Medicine (CINIM)
Calgary, Alberta, Canada, T2M 3T1